ClinicalTrials.gg
RecruitingNCT07702058Updated Jul 14, 2026

Mindfulness-Based Postpartum Discharge Education on Maternal Role and Anxiety

An observational study in Postpartum Period, Anxiety and Maternal Behavior, sponsored by Tokat Gaziosmanpasa University. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-14.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Tokat Gaziosmanpasa University · Observational

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
84
Ages
18 Years and older
Sex
Female
01

Study summary

This study will be conducted as a quasi-experimental research with a pretest-posttest control group design at the Obstetrics and Gynecology Clinic of Tokat Gaziosmanpaşa University Research and Practice Hospital, aiming to evaluate the effects of mindfulness-based postpartum discharge education on mothers' maternal role perception and anxiety levels. The sample will consist of 84 postpartum women (42 in the experimental group and 42 in the control group) who meet the inclusion criteria, determined through G*Power analysis. Stratified randomization will be used for group allocation. Data will be collected using a Personal Information Form, the Maternal Role Perception Scale, and the Postpartum Specific Anxiety Scale. Within the first 24 hours postpartum (baseline/pretest), the experimental group will receive a 60-minute individual "Mindfulness-Based Postpartum Education Program" administered by the researcher in addition to routine discharge care, while the control group will receive only standard hospital discharge education. One week after the education, a second measurement will be applied to both groups. Subsequently, the experimental group will be systematically followed up for one month via WhatsApp with weekly reminder messages and monitoring charts. At the end of the first postpartum month (30th day), the final posttest measurements will be completed. The effects of the education over repeated time points will be analyzed using SPSS 22.0 software with descriptive statistics, parametric tests (Independent/Paired Sample t-test, repeated measures Two-Way ANOVA, Pearson correlation), and non-parametric tests (Mann Whitney U, Wilcoxon, Spearman correlation) at a significance level of 0.05.

02

Conditions studied

  • Postpartum Period
  • Anxiety
  • Maternal Behavior

Browse trials for

Keywords

  • Mindfulness
  • Maternal Role
  • Discharge Education
  • Midwifery
03

In context

Anxiety Disorders Unverified

7,207 studies on the registry are indexed under Anxiety Disorders; 1,682 are open to participants now.

This study's planned enrollment of 84 is below the median of 168 across 978 observational studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Tokat Gaziosmanpasa University is the lead sponsor of 170 studies on the registry; 38 are open to participants now.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Postpartum women aged 18 and older who had a healthy singleton birth and are hospitalized in the Obstetrics and Gynecology Clinic of Tokat Gaziosmanpasa University Research and Practice Hospital within their first 24 hours postpartum.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Mothers aged 18 and older who voluntarily agree to participate in the study
  • Mothers who have had a healthy singleton birth
  • Mothers who are in the postpartum ward within the first 24 hours after delivery
  • Mothers living in the same home environment with their baby
  • Mothers who can read and understand Turkish and fully complete the questionnaires
  • Mothers who can use mobile communication tools (e.g., WhatsApp)
  • Mothers whose health status is suitable to participate in the education process

Exclusion criteria

Exclusion Criteria:

  • Mothers with serious physical or psychiatric illnesses in the postpartum period
  • Mothers whose newborns are admitted to the intensive care unit or have serious health problems
  • Mothers who have previously participated in a mindfulness-based education or therapy program
  • Mothers who cannot participate regularly in the education process or maintain communication during the follow-up period
  • Mothers who incompletely fill out the questionnaires or do not participate in the post-test phase
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
84 participants (estimated)
Patient registry
No

Groups and cohorts

  • Experimental Group

    Mothers in this group will receive a mindfulness-based discharge education program.

  • Control Group

    Mothers in this group will receive standard routine hospital discharge care.

06

What researchers measure

Primary outcomes

  1. Maternal Role Perception

    Evaluated using the Maternal Role Perception Scale developed by Arpaci Kizildag and Yigit (2022). The scale consists of 26 items scored on a 5-point Likert-type scale (1=Strongly Disagree to 5=Strongly Agree) and includes reversed items. The total score ranges from 26 to 130. A total score of 26 indicates the lowest (worst) level of maternal role perception, while a total score of 130 indicates the highest (best) and most advanced level of maternal role perception. Higher scores signify a better and more developed perception of the maternal role.

    Time frame: Within the first 24 hours postpartum (baseline), at 1 week postpartum, and at 1 month postpartum.

Secondary outcomes

  1. Postpartum Specific Anxiety Scale

    Evaluated using the Postpartum Specific Anxiety Scale - Turkish Version (PSAS-TR) adapted by Duran (2019). The scale consists of 47 items scored on a 4-point Likert-type scale (1=Never to 4=Almost always). The total score ranges from 47 to 188. Higher scores signify a higher level of postpartum anxiety. Specifically, a total score of 73 or below indicates low anxiety, a score between 74 and 100 indicates moderate anxiety, and a score of 101 or above indicates a high level of postpartum anxiety.

    Time frame: Within the first 24 hours postpartum (baseline), at 1 week postpartum, and at 1 month postpartum.

07

Study locations

1 of 1 sites recruiting
  • Tokat Gaziosmanpasa University University Hospital
    Tokat Province, Tokat Province 60100, Turkey (Türkiye)
    Recruiting
    • Damlagul ACAR, MSc Student · Contactdamlagul.acar7825@gop.edu.tr · +90 552 829 30 11
    • Damlagul ACAR, MSc Student · Principal investigator
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Sep 2026, 2 months after the start.

Of 411 non-industry observational studies under Anxiety Disorders, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 49. This study's planned 2 months is below that.

Counting every sponsor, half of 439 studies reached it within 19 months; a quarter within 6 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 9, 2026
First posted
Jul 14, 2026
StartActual
Jul 9, 2026
Primary completionEst.
Sep 9, 2026
CompletionEst.
Dec 31, 2026
Last update
Jul 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07702058
Responsible party
Damlagül ACAR (Midwife and Graduate Student, Tokat Gaziosmanpasa University) — Principal investigator
First posted
Jul 14, 2026
Start date
Jul 9, 2026
Primary completion
Sep 9, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jul 14, 2026

Study contacts

Damlagul ACAR, MSc Student
Contact
damlagul.acar7825@gop.edu.tr
+90 552 829 30 11

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion